Out of 16 manufacturing facilities three world class state of the art WHO GMP certified USFDA compliant manufacturing unit are catering for requirement of Exports:
Spread in a Total Area of 18000 Sq.metre, the unit manufactures Injectable (Both Vials & Ampoules). Unit I can manufacture 5mn Ampoules per month and 1.2 million vials per month.
It already has to its credit the following regulatory approvals:WHO GMP / PPB Kenya /Ethiopia / Uganda
Spread in a Total Area of 25000 Sq.metre, the unit manufactures Dry syrup, Liquid syrups, Extended Release Tablets / Capsules, Bi-layered Tablets. Unit II can manufacture 30 million tablets per month, 10mln Soft gelatine capsules per month, and 6 million bottles of oral liquid per month.
It already has to its credit the following regulatory approvals: WHO GMP / PPB Kenya /Ethiopia/Uganda.
Spread in a Total Area of 3000 Sq.metre, the unit manufactures immediate release/ modified release tablets. Unit III can manufacture 60 million tablets per month.
It already has to its credit the following regulatory approvals: WHO GMP / PPB Kenya
The API facility at Sotanala, Behror is created as state of art facility with adequate space and operational convenience. The facility has automation at all safety prone areas of operation and is created to cater the requirement of regulatory market. The quality block is equipped with advance instruments, required for ensuring high quality products.
One more new production facility is setting up in green valley of Sikkim state, which is expected to commence production early in 2017. It will focus on producing oral solid dosage forms.